Transforming Non-clinical Drug Development with SEND Explorer Case Study Transforming Non-clinical Drug Development with SEND Explorer Since 1999, Genmab has been developing therapeutic antibodies and antibody-drug conjugates (ADCs) for treating cancer.…CertaraJuly 8, 2024
What’s New for SEND 2023 On-Demand Webinar What’s New for SEND 2023 This webinar will focus on several changes to the CDISC SEND standard that became active…CertaraJune 12, 2023
American College of Toxicology 2026 Annual Meeting Conference American College of Toxicology 2026 Annual Meeting – – BoothCertaraMay 24, 2023
Data Visualization with SEND Data to See What Happened at the Preclinical Phase On-Demand Webinar Data Visualization with SEND Data to See What Happened at the Preclinical Phase SEND is an implementation of CDISC’s (Clinical Data Interchange Standards Consortium) SDTM (Study Data Tabulation…CertaraFebruary 9, 2023